Journal article · 2026 · Open access

Clinical Pharmacology in Transgender Medicine: What Gaps Remain?

Lauren R. Cirrincione

Clinical Pharmacology & Therapeutics · Published 2 November 2026 · DOI 10.1002/cpt.70549

Open PDFView at the publisherCite this paper

In brief

“Clinical Pharmacology in Transgender Medicine: What Gaps Remain?” is a 2026 journal article by Lauren R. Cirrincione, published in Clinical Pharmacology & Therapeutics. OpenAlex counts 0 citations as of 17 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at Clinical Pharmacology & Therapeutics.

Citations
0
References
9
Authors
1

Abstract

Mechanistic information is limited about the effects of gender-affirming hormone therapy and the unique factors that influence the absorption, distribution, metabolism, and excretion properties of medications across therapeutic classes for transgender people. Opportunities exist to address knowledge gaps in transgender medicine using well-designed probe substrate studies, endogenous biomarkers of drug-metabolizing enzymes and transporters, and real-world data to identify and address factors that contribute to interindividual variability in drug disposition for transgender people across the life course.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Cirrincione, L. R. (2026). Clinical Pharmacology in Transgender Medicine: What Gaps Remain? Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70549

MLA 9

Cirrincione, Lauren R. “Clinical Pharmacology in Transgender Medicine: What Gaps Remain?” Clinical Pharmacology & Therapeutics, 2026. https://doi.org/10.1002/cpt.70549.

Chicago

Cirrincione, Lauren R. 2026. “Clinical Pharmacology in Transgender Medicine: What Gaps Remain?” Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70549.

Harvard

Cirrincione, L. R. (2026) ‘Clinical Pharmacology in Transgender Medicine: What Gaps Remain?’, Clinical Pharmacology & Therapeutics. doi:10.1002/cpt.70549.

IEEE

L. R. Cirrincione, “Clinical Pharmacology in Transgender Medicine: What Gaps Remain?,” Clinical Pharmacology & Therapeutics, 2026, doi: 10.1002/cpt.70549.

BibTeX

@article{cirrincione2026clinical,
  title     = {{Clinical Pharmacology in Transgender Medicine: What Gaps Remain?}},
  author    = {Cirrincione, Lauren R.},
  journal   = {Clinical Pharmacology \& Therapeutics},
  year      = {2026},
  doi       = {10.1002/cpt.70549},
  url       = {https://doi.org/10.1002/cpt.70549}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism

  • transgender medicine
  • gender-affirming hormone therapy
  • drug disposition
  • pharmacokinetics
  • pharmacodynamics
  • drug-metabolizing enzymes
  • drug transporters
  • endogenous biomarkers

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Cirrincione, L. R. (2026). Clinical Pharmacology in Transgender Medicine: What Gaps Remain? Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70549

How many times has this paper been cited?

0 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Clinical Pharmacology & Therapeutics: sign in and open the PDF from this page.

Who wrote this paper?

Lauren R. Cirrincione.

What is the DOI of this paper?

10.1002/cpt.70549, permanently at https://doi.org/10.1002/cpt.70549. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.